Ads
related to: coding guidelines for diabetes
Search results
Results From The WOW.Com Content Network
ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup A10 is part of the anatomical group A Alimentary tract and ...
Since its establishment it developed several evidence-based guidelines or wherever possible expert consensus to drive quality of inpatient diabetes care. [3] [4] The guidelines have been widely used across the UK and helped reduce variations by standardising approach to inpatient diabetes care. [1] Hypoglycaemia [5]
In 2009, the comprehensive "ISPAD Clinical Practice Consensus Guidelines" were published as a compendium in Pediatric Diabetes. These are evidence-based guidelines compiled under the editorship of Dr Peter Swift, former Secretary General of ISPAD with the co-authors Ragnar Hanas, Kim C. Donaghue and Georgeanna Klingensmith.
A clinical coder—also known as clinical coding officer, diagnostic coder, medical coder, or nosologist—is a health information professional whose main duties are to analyse clinical statements and assign standardized codes using a classification system.
The ICD-10 Procedure Coding System (ICD-10-PCS) is a US system of medical classification used for procedural coding.The Centers for Medicare and Medicaid Services, the agency responsible for maintaining the inpatient procedure code set in the U.S., contracted with 3M Health Information Systems in 1995 to design and then develop a procedure classification system to replace Volume 3 of ICD-9-CM.
A subscription-based product of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), MedDRA or Medical Dictionary for Regulatory Activities is a clinically validated international medical terminology dictionary-thesaurus used by regulatory authorities and the biopharmaceutical industry during the regulatory process, from pre-marketing ...